In this episode, we explore the latest research on stem cell therapy for lung disease and whether it can support people living with COPD and pulmonary fibrosis. We discuss what current clinical trials reveal, where the evidence is strongest, and what realistic expectations patients should have before considering this emerging treatment.

You’ll learn:

• Why COPD and pulmonary fibrosis cause permanent lung damage and are difficult to treat
• How mesenchymal stem cell (MSC) therapy may reduce inflammation and support the body's natural repair processes
• What the largest clinical trial found about stem cell therapy for COPD
• How umbilical cord-derived stem cells may improve the quality of life for some patients
• What current research says about stem cell therapy for pulmonary fibrosis
• Why major health organizations urge caution when evaluating unproven stem cell treatments
• How stem cell therapy may complement pulmonary rehabilitation rather than replace standard care
• The key questions patients should ask before exploring stem cell therapy for chronic lung disease

While stem cell therapy for lung disease continues to show encouraging safety and quality-of-life results, it is not a cure for COPD or pulmonary fibrosis. This episode explains the latest evidence, the limitations of current research, and how patients can make informed decisions alongside their healthcare team.

Blog Link: Stem Cell Therapy For Lungs: Can It Support COPD and Pulmonary Fibrosis?